In P-gp modulation-mechanism analysis, it was further established that the compounds reverse the sensitivities of multidrug (MDR) cancer cell lines by the inhibition of the P-glycoprotein (P-gp) [41]. The gene discussed is ABCB1; the disease is cancer.